Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 911 of 6351
-
Smart scans guide radiation to kill sarcoma more effectively
Disease control Recruiting nowThe purpose of the study is to utilize radiomic images to precisely locate areas of tumor that can be treated with dose escalation radiation therapy.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy aims to stall ALK-Positive lung cancer
Disease control OngoingThis is a phase II randomized, open-labelled, non-comparative multicenter study in which ALK+ NSCLC patients who are naïve of treatment for advanced disease will be randomized to receive brigatinib monotherapy (Arm A) or brigatinib and carboplatin-pemetrexed therapy (Arm B). An e…
Phase 2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can tailored school support boost behavior and language in kids with ADHD?
Disease control OngoingThe goal of this clinical trial is to compare the effect of language and behavioral interventions for students who are English language learners and who have symptoms of attention-deficit/hyperactivity disorder (ADHD). The main question it aims to answer is: \- Which interventio…
Sponsor: Florida International University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Mix-and-Match COVID boosters tested in african teens and adults
Vaccine CompletedSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that emerged in the human population in Wuhan City, Hubei Province, China in December 2019. As of Jan 2022, there are over 328 million SARS-CoV-2 case worldwide and over 5.54 million deaths as a r…
Phase 2 • Sponsor: Victoria Biomedical Research Institute • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy shows promise for rare melanoma
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before. The researchers think that a combination of axitinib an…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for stomach cancer: targeted drug combo enters human trials
Disease control Stopped earlyThe main objectives of this study are to evaluate the safety and tolerability of bemarituzumab in combination with other anti-cancer therapies, and to evaluate the efficacy of bemarituzumab in combination with S-1 and oxaliplatin (SOX) and nivolumab as assessed by objective respo…
Phase 1/2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Downhill treadmill training with electric zaps may help spinal injury patients walk again
Disease control Recruiting nowThe investigators are studying a new rehabilitation treatment for individuals trying to recover walking after spinal cord injury (SCI). The investigators will test conditions in the blood and spinal fluid to determine the best time to start this new training program. This will in…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Immunotherapy plus chemotherapy shows promise against tough nasopharyngeal cancer
Disease control OngoingThis randomized clinical trial determining whether Sintilimab plus Capecitabine versus Capecitabine alone can improve the progression-free survival rate of NPC patients with unfavorable response to induction chemotherapy. Patients whose plasma EBV DNA\> 0 copy/mL or SD/PD accordi…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Brain zaps for stubborn OCD: new hope for Therapy-Resistant patients
Symptom relief Recruiting nowTETRO is a multi-center placebo-controlled double-blind randomized controlled trial with an intervention phase of 5-7 weeks and a follow-up phase of 12 months in 250 adult (18 years and older) OCD patients who show no/insufficient response to ERP, aiming to establish the cost-eff…
Phase 3 • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Fat cell 'Messages' may harm blood vessels — can exercise or surgery stop them?
Knowledge-focused Recruiting nowThe development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patient…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
One-Week radiation for breast cancer: MRI precision may cut side effects
Disease control Recruiting nowThis trial will investigate a novel 3-fraction radiation regimen for participants undergoing breast-conserving therapy (BCT) for early breast cancer that will: 1) significantly reduce the duration of treatment and can be completed in one-week (5 working days) and 2) MRI-guided ra…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New malaria vaccine passes early safety test in kids
Vaccine CompletedThis is a Phase Ib trial conducted in Bougouni, Mali to evaluate the safety and immunogenicity of R21/Matrix-M in a single and two vial presentation, with different immunisation schedules, and when co-administered with EPI vaccines in African children.
Phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail aims to wipe out rectal cancer before surgery
Disease control PausedTo evaluate the safety and preliminary efficacy of Preoperative ChemoRadiation and FOLFOXIRI and to Escalate Complete Response for Rectal Cancer patients.Go through laboratory and medical tests to verify eligibility to enter the study, receive the experimental combination of drug…
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug cocktail aims to boost myeloma remission before transplant
Disease control PausedThis is a multi-institution, open label, phase I/II study of Iberdomide, Carfilzomib, and dexamethasone (KID) in patients with newly diagnosed transplant eligible MM.
Phase 1/2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Peer power: could a team approach lower stroke risk?
Prevention CompletedThe proposed 2-phase project will first refine the TargetEd MAnageMent (TEAM) intervention to ensure acceptability across a broad range of Ugandans at risk for stroke and then test the effects of TEAM in reducing stroke risk in a 3-site, prospective, 6-month randomized controlled…
Sponsor: Case Western Reserve University • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can less radiation be just as good for HPV throat cancer?
Disease control CompletedOropharyngeal squamous cell carcinoma (OPSCC), commonly known as throat cancer or tonsil cancer, has seen a dramatic rise in incidence over the last twenty years. There are two types of OPSCC: human papillomavirus-positive (HPV+) and human papillomavirus-negative (HPV-). People w…
Sponsor: Indiana University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New heart valve system offers hope for patients with leaky pulmonary valves
Disease control OngoingThis study will monitor device performance and outcomes in subjects undergoing implantation of the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent in the post-approval setting
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo aims to stop MDS return after transplant
Disease control Recruiting nowThe investigators hypothesize that early measurable residual disease (MRD)-guided pre-emptive therapy with decitabine + cedazaridine (DEC-C) will decrease the risk of progression in post-transplant myelodysplastic syndromes (MDS) patients with persistent mutations (molecular MRD)…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
App-Based support aims to boost opioid recovery during pandemic
Disease control OngoingThe COVID-19 pandemic puts individuals recovering from opioid use disorders (OUDs), an already vulnerable population, at increased risk of overdose due to decreased access to treatment, decreased social support, and increased psychosocial stress. This proposal will test the effic…
Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for rare lung cancer? poziotinib trial targets HER2 mutations
Disease control PausedThe primary purpose of this study is to compare the progression-free survival (PFS) in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring human epidermal growth factor receptor 2 (HER2) exon 20 mutations when treated with poziotinib vers…
Phase 3 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC